UFF
IBB icon

USA Financial Formulas’s iShares Biotechnology ETF IBB Stock Holding History

USA Financial Formulas’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-32,874
Closed -$4.04M – 146
2015
Q2 		$4.04M Buy
+32,874
New +$3.94M 1.24% 21

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

USA Financial Formulas's IBB Position: Q3 2015 in Review

USA Financial Formulas sold out of iShares Biotechnology ETF (IBB) in Q3 2015, closing a stake of 32,874 shares — an estimated $4.04M sold.

USA Financial Formulas first reported a position in IBB in Q2 2015 and held it in 1 quarter. The position peaked at $4.04M in Q2 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

  • USA Financial Formulas reported no remaining iShares Biotechnology ETF position as of Q3 2015 after selling out during the quarter.
  • USA Financial Formulas sold 32,874 iShares Biotechnology ETF shares in Q3 2015, an estimated $4.04M.
  • USA Financial Formulas first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 1 quarter.
  • USA Financial Formulas's iShares Biotechnology ETF position peaked at $4.04M in Q2 2015.
  • 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on USA Financial Formulas's 13F filing for Q3 2015, filed 16 Nov 2015.